NCT00640107 Evaluation and Optimization of Ultrasound and/or MRI Hardware and Software
| NCT ID | NCT00640107 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State University of New York - Upstate Medical University |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2007-10 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2007-10 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate and optimize ultrasound and/or MRI hardware and software in both existing ultrasound/MRI units as well as in newly installed commercially available ultrasound/MRI units. The study also serves to familiarize the ultrasound/MRI technician staff with how to operate newly installed software sequences or hardware. The information obtained from this study will be utilized to optimize new software sequences and hardware that have been installed on the UMU ultrasound/MRI scanners. This will offer ultrasound/MRI technologists ample time to become familiar with the operation of new equipment. More specifically, the objectives of this study are to maximize contrast to noise (CNR) and signal to noise (SNR) ratios for new imaging sequences and hardware to obtain high quality images, maximize the potential of new machines and associated software/hardware to obtain the highest quality of images, and obtain the highest quality images in reasonable scan time to minimize patient motion.
Eligibility Criteria
Inclusion Criteria: * Able to Understand and Sign Informed Consent Disclosure (ICD) * Healthy Volunteers Aged 18-70 * Healthy Volunteers with No History of Aneurysm Clips, Cardiac Pacemakers, Claustrophobia, Neurostimulators, and Pregnancy. Exclusion Criteria: * Subjects \> 300 Pounds * Subjects \< 18 Years Old * Subjects \> 70 Years Old * Subjects w/ Aneurysm Clips * Subjects w/ Cardiac Pacemakers * Subjects w/ Claustrophobia * Subjects w/ Neurostimulators * Subjects w/ Pregnancy
Contact & Investigator
Marzieh Nezamzadeh, PhD
PRINCIPAL INVESTIGATOR
State University of New York - Upstate Medical University
Frequently Asked Questions
Who can join the NCT00640107 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00640107 currently recruiting?
Yes, NCT00640107 is actively recruiting participants. Contact the research team at bolourcd@upstate.edu for enrollment information.
Where is the NCT00640107 trial being conducted?
This trial is being conducted at Syracuse, United States.
Who is sponsoring the NCT00640107 clinical trial?
NCT00640107 is sponsored by State University of New York - Upstate Medical University. The principal investigator is Marzieh Nezamzadeh, PhD at State University of New York - Upstate Medical University. The trial plans to enroll 30 participants.